124 related articles for article (PubMed ID: 25060327)
21. Tumor characteristics and recurrence patterns in triple negative breast cancer: a comparison between younger (<65) and elderly (≥65) patients.
Königsberg R; Pfeiler G; Klement T; Hammerschmid N; Brunner A; Zeillinger R; Singer C; Dittrich C
Eur J Cancer; 2012 Nov; 48(16):2962-8. PubMed ID: 22647688
[TBL] [Abstract][Full Text] [Related]
22. MR imaging features of triple-negative breast cancers.
Sung JS; Jochelson MS; Brennan S; Joo S; Wen YH; Moskowitz C; Zheng J; Dershaw DD; Morris EA
Breast J; 2013; 19(6):643-9. PubMed ID: 24015869
[TBL] [Abstract][Full Text] [Related]
23. In vivo magnetic resonance imaging investigating the development of experimental brain metastases due to triple negative breast cancer.
Hamilton AM; Foster PJ
Clin Exp Metastasis; 2017 Feb; 34(2):133-140. PubMed ID: 28108861
[TBL] [Abstract][Full Text] [Related]
24. The clinical, molecular, and therapeutic implications of time from primary diagnosis to brain metastasis in lung and breast cancer patients.
Ge H; Zhu K; Sun Q; Wang H; Liu H; Ge J; Liu C; Liang P; Lv Z; Bao H
Cancer Med; 2024 Jun; 13(11):e7364. PubMed ID: 38847084
[TBL] [Abstract][Full Text] [Related]
25. [Breast cancer with triple-negative phenotype in the Russian patient population. Clinical and morphologic features].
Zhukova LG
Vopr Onkol; 2015; 61(2):189-94. PubMed ID: 26087596
[TBL] [Abstract][Full Text] [Related]
26. Outcome of triple negative breast cancer: comparison of sporadic and BRCA1-associated cancers.
Tung N; Gaughan E; Hacker MR; Lee LJ; Alexander B; Poles E; Schnitt SJ; Garber JE
Breast Cancer Res Treat; 2014 Jul; 146(1):175-82. PubMed ID: 24839033
[TBL] [Abstract][Full Text] [Related]
27. Primary relapse site pattern in women with triple-negative breast cancer.
Beca F; Santos R; Vieira D; Zeferino L; Dufloth R; Schmitt F
Pathol Res Pract; 2014 Sep; 210(9):571-5. PubMed ID: 24939141
[TBL] [Abstract][Full Text] [Related]
28. Predictive factors and patterns of recurrence in patients with triple negative breast cancer.
Steward L; Conant L; Gao F; Margenthaler JA
Ann Surg Oncol; 2014 Jul; 21(7):2165-71. PubMed ID: 24558065
[TBL] [Abstract][Full Text] [Related]
29. Identification of patients with node-negative, triple-negative breast cancer who benefit from adjuvant cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy.
Wu CE; Chen SC; Lin YC; Lo YF; Hsueh S; Chang HK
Anticancer Res; 2014 Mar; 34(3):1301-6. PubMed ID: 24596377
[TBL] [Abstract][Full Text] [Related]
30. [Clinicopathological features and prognosis of triple-negative breast cancer].
Li CY; Wang P; Zhang S; Liu Y; Zhang J
Zhonghua Zhong Liu Za Zhi; 2013 Jun; 35(6):463-7. PubMed ID: 24119909
[TBL] [Abstract][Full Text] [Related]
31. A quantitative characterization of the spatial distribution of brain metastases from breast cancer and respective molecular subtypes.
Mahmoodifar S; Pangal DJ; Cardinal T; Craig D; Simon T; Tew BY; Yang W; Chang E; Yu M; Neman J; Mason J; Toga A; Salhia B; Zada G; Newton PK
J Neurooncol; 2022 Oct; 160(1):241-251. PubMed ID: 36245013
[TBL] [Abstract][Full Text] [Related]
32. Subtypes of breast cancer show different spatial distributions of brain metastases.
Kyeong S; Cha YJ; Ahn SG; Suh SH; Son EJ; Ahn SJ
PLoS One; 2017; 12(11):e0188542. PubMed ID: 29155879
[TBL] [Abstract][Full Text] [Related]
33. Triple-negative breast cancer survival in Iranian patients.
Aghili M; Lashkari M; Farrokhpey AH; Izadi S
Acta Med Iran; 2013 Sep; 51(8):560-6. PubMed ID: 24026994
[TBL] [Abstract][Full Text] [Related]
34. Survival in patients with brain metastases from breast cancer: the importance of HER-2 status.
Eichler AF; Kuter I; Ryan P; Schapira L; Younger J; Henson JW
Cancer; 2008 Jun; 112(11):2359-67. PubMed ID: 18361426
[TBL] [Abstract][Full Text] [Related]
35. Surgical resection of brain metastases from breast cancer in the modern era: clinical outcome and prognostic factors.
Tabouret E; Metellus P; Tallet-Richard A; Figarella-Branger D; Charaffe-Jauffret E; Viens P; Gonçalves A
Anticancer Res; 2013 May; 33(5):2159-67. PubMed ID: 23645770
[TBL] [Abstract][Full Text] [Related]
36. Mesothelin expression in triple negative breast carcinomas correlates significantly with basal-like phenotype, distant metastases and decreased survival.
Tozbikian G; Brogi E; Kadota K; Catalano J; Akram M; Patil S; Ho AY; Reis-Filho JS; Weigelt B; Norton L; Adusumilli PS; Wen HY
PLoS One; 2014; 9(12):e114900. PubMed ID: 25506917
[TBL] [Abstract][Full Text] [Related]
37. A new, preoperative, MRI-based scoring system for diagnosing malignant axillary lymph nodes in women evaluated for breast cancer.
He N; Xie C; Wei W; Pan C; Wang W; Lv N; Wu P
Eur J Radiol; 2012 Oct; 81(10):2602-12. PubMed ID: 22525596
[TBL] [Abstract][Full Text] [Related]
38. Efficiency and prognosis of whole brain irradiation combined with precise radiotherapy on triple-negative breast cancer.
Wu X; Luo B; Wei S; Luo Y; Feng Y; Xu J; Wei W
J Cancer Res Ther; 2013 Nov; 9 Suppl():S169-72. PubMed ID: 24516055
[TBL] [Abstract][Full Text] [Related]
39. Detection of brain metastases from small cell lung cancer: consequences of changing imaging techniques (CT versus MRI).
Seute T; Leffers P; ten Velde GP; Twijnstra A
Cancer; 2008 Apr; 112(8):1827-34. PubMed ID: 18311784
[TBL] [Abstract][Full Text] [Related]
40. Brain metastases from breast cancer using magnetic resonance imaging: A systematic review.
Mohammadi M; Mohammadi S; Hadizadeh H; Olfati M; Moradi F; Tanzifi G; Ghaderi S
J Med Radiat Sci; 2024 Mar; 71(1):133-141. PubMed ID: 37563948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
